The role of Tau protein in resistance to paclitaxel Marta SmoterLubomir BodnarCezary Szczylik Mini Review Open access 29 June 2011 Pages: 553 - 557
Involvement of RhoA and RalB in geranylgeranyltransferase I inhibitor-mediated inhibition of proliferation and migration of human oral squamous cell carcinoma cells Masakazu HamadaTetsuei MikiYoshiaki Yura Original Article 25 November 2010 Pages: 559 - 569
Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy Niranjan AwasthiMargaret A. SchwarzRoderich E. Schwarz Original Article 26 November 2010 Pages: 571 - 582
Induction of fetal hemoglobin and ABCB1 gene expression in 9-β-D-arabinofuranosylguanine-resistant MOLT-4 cells Anna FyrbergCurt PetersonKourosh Lotfi Original Article 26 November 2010 Pages: 583 - 591
Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats Izet M. KapetanovicMiguel MuzzioDavid L. McCormick Original Article 30 November 2010 Pages: 593 - 601
Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells Yan LiJezrael L. RevaldeJames W Paxton Original Article 30 November 2010 Pages: 603 - 610
Phase II study of sequential treatment with S-1 and cisplatin for metastatic gastric cancer Eishi BabaTaito EsakiKoichi Akashi Original Article 30 November 2010 Pages: 611 - 617
Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer Wei YuLi ChenJing Yang Original Article 01 December 2010 Pages: 619 - 629
A two-part Phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics Claire L. MitchellJ. P. B. O’ConnorG. C. Jayson Original Article 01 December 2010 Pages: 631 - 641
A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients Jonathan HebbSarit AssoulineLawrence Panasci Original Article 01 December 2010 Pages: 643 - 651
Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients Toshiaki TakahashiYukiko NakamuraNobuyuki Yamamoto Original Article Open access 02 December 2010 Pages: 653 - 659
Primary tumor and patient characteristics in breast cancer as predictors of adjuvant therapy regimen: a regression model Valerie FrancescuttiForough FarrokhyarKamyar Kahnamoui Original Article 02 December 2010 Pages: 661 - 668
Over-expression of MDR1 in amrubicinol-resistant lung cancer cells Osamu TakakuwaTetsuya OguriShigeki Sato Original Article 03 December 2010 Pages: 669 - 676
Prospective multicenter study to investigate the introduction rate of second-line S-1 in gemcitabine-refractory unresectable pancreatic cancer Hiroki KawashimaAkihiro ItohYoshiki Hirooka Original Article 05 December 2010 Pages: 677 - 683
Effects of endurance training on combined goserelin acetate and doxorubicin treatment–induced cardiac dysfunction David S. HydockTraci L. ParryReid Hayward Original Article 05 December 2010 Pages: 685 - 692
Evaluation of a non cystatin-C-based novel algorithm to calculate individual glomerular filtration rate in cancer patients receiving carboplatin Karin HolwegerHans-Peter LippJoerg Thomas Hartmann Original Article 07 December 2010 Pages: 693 - 701
Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results Elisabeth I. HeathGeorge R. Blumenschein JrGeorge Wilding Original Article 08 December 2010 Pages: 703 - 712
Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice Pedro M. G. SoaresRoberto C. P. Lima-JuniorMarcellus H. L. P. Souza Original Article 14 December 2010 Pages: 713 - 720
Effect of radiation on the penetration of irinotecan in rat cerebrospinal fluid Amit KhatriM. Waleed GaberMark N. Kirstein Original Article 16 December 2010 Pages: 721 - 731
Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumors T. DoiH. MurakamiT. Sasaki Original Article 16 December 2010 Pages: 733 - 741
Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer Su Jin LeeYoon La ChoiYoung-Hyuck Im Original Article 18 December 2010 Pages: 743 - 751
Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC) Eun Yoon ChoMyung Hee ChangYoung-Hyuck Im Original Article 18 December 2010 Pages: 753 - 761
Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer Satoshi MatsusakaMitsukuni SuenagaKiyohiko Hatake Original Article 18 December 2010 Pages: 763 - 768
Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer M. TaharaH. MinamiM. Tsukuda Original Article 24 December 2010 Pages: 769 - 776
Pharmacokinetics, pharmacodynamics and metabolism of the dimeric pyrrolobenzodiazepine SJG-136 in rats Joel M. ReidSarah A. BuhrowMatthew M. Ames Original Article 28 December 2010 Pages: 777 - 786
Preoperative radiotherapy with capecitabine and mitomycin C in locally advanced rectal carcinoma Suzana StojanovicIvan PopovIva Kezic Original Article 28 December 2010 Pages: 787 - 793
The slow cell death response when screening chemotherapeutic agents Joseph BloisAdam SmithLee Josephson Original Article 31 December 2010 Pages: 795 - 803
Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitor Paul HambergMargaret M. WooMaja de Jonge Clinical Trial Report Open access 26 June 2011 Pages: 805 - 813
Methylseleninic acid inhibits HDAC activity in diffuse large B-cell lymphoma cell lines Shireen KassamHeidi Goenaga-InfanteSimon P. Joel Short Communication 26 April 2011 Pages: 815 - 821
5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases Pierre-Yves CordierAndré NauEric Peytel Short Communication 08 May 2011 Pages: 823 - 826